Article: Severe Psoriasis Presenting in 3-Year-Old Child With Nail Dystrophy: Response to Biologic Treatment.
Journal of drugs in dermatology : JDD
2022 Volume 21, Issue 8, Page(s) 897–899
Abstract: Psoriasis, a chronic inflammatory skin condition, affects about 2% of children. A small subset have isolated nail involvement refractory to topical treatment that can be disabling. The development of targeted biologic agents offers safe, effective ... ...
Abstract | Psoriasis, a chronic inflammatory skin condition, affects about 2% of children. A small subset have isolated nail involvement refractory to topical treatment that can be disabling. The development of targeted biologic agents offers safe, effective options for children with moderate-to-severe skin and nail disease. A few are now Food and Drug Administration (FDA)-approved for children. J Drugs Dermatol. 2022;21(8):897-899. doi:10.36849/JDD.6888. |
---|---|
MeSH term(s) | Biological Products/adverse effects ; Child, Preschool ; Humans ; Nail Diseases/diagnosis ; Nail Diseases/drug therapy ; Nails ; Psoriasis/diagnosis ; Psoriasis/drug therapy ; Treatment Outcome |
Chemical Substances | Biological Products |
Language | English |
Publishing date | 2022-08-10 |
Publishing country | United States |
Document type | Case Reports ; Journal Article |
ZDB-ID | 2145090-0 |
ISSN | 1545-9616 |
ISSN | 1545-9616 |
DOI | 10.36849/JDD.6888 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 5931: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.